Separation Agreements in the Biotechnology Industry

679 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
ABEONA THERAPEUTICS INC. (2)
ACCELERON PHARMA INC (1)
Achaogen, Inc. (2)
ACHIEVE LIFE SCIENCES, INC. (1)
Acorda Therapeutics (1)
Actinium Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (1)
Adamas Pharmaceuticals Inc (1)
ADiTx Therapeutics, Inc. (3)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (5)
Advaxis, Inc. (3)
Adverum Biotechnologies, Inc. (11)
AGENUS INC (1)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (1)
AILERON THERAPEUTICS INC (2)
Aimmune Therapeutics, Inc. (3)
AKCEA THERAPEUTICS, INC. (5)
Akebia Therapeutics, Inc. (3)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (2)
Alector, Inc. (1)
Alexion Pharmaceuticals (3)
Alkermes plc. (1)
Allakos Inc. (2)
Allarity Therapeutics, Inc. (2)
Alliqua BioMedical, Inc. (3)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (4)
Altimmune, Inc. (4)
AMARIN CORP PLC (3)
AMICUS THERAPEUTICS, INC. (1)
AmpliPhi Biosciences Corp (3)
Amplitude Healthcare Acquisition Corp (1)
ANAPTYSBIO INC (1)
Anika Therapeutics (1)
Annovis Bio, Inc. (1)
Applied Molecular Transport Inc. (3)
Applied Therapeutics Inc. (1)
Aprea Therapeutics, Inc. (4)
Aptevo Therapeutics Inc. (1)
AQUINOX PHARMACEUTICALS, INC (3)
Aravive, Inc. (6)
Arbutus Biopharma Corp (1)
Arcus Biosciences, Inc. (1)
ARDELYX, INC. (4)
ARENA PHARMACEUTICALS INC (1)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (2)
Atara Biotherapeutics, Inc. (1)
ATHERSYS, INC (1)
ATOSSA GENETICS INC (1)
aTYR PHARMA INC (2)
Aurinia Pharmaceuticals Inc. (4)
AVEO PHARMACEUTICALS INC (3)
Avid Bioservices, Inc. (1)
AVROBIO, Inc. (3)
Axcella Health Inc. (2)
Axovant Sciences Ltd. (5)
AZIYO BIOLOGICS, INC. (1)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (2)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOMARIN PHARMACEUTICAL INC (1)
Biomea Fusion, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
Biostage, Inc. (4)
BIOTIME INC (3)
BioXcel Therapeutics, Inc. (5)
Black Diamond Therapeutics, Inc. (1)
bluebird bio, Inc. (3)
BRAINSTORM CELL THERAPEUTICS INC. (2)
CALADRIUS BIOSCIENCES, INC. (1)
Calyxt, Inc. (5)
CANCER GENETICS, INC (1)
CAPRICOR THERAPEUTICS, INC. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
Capstone Therapeutics Corp. (1)
CASI Pharmaceuticals, Inc. (1)
CASTLE BIOSCIENCES INC (2)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (3)
Celldex Therapeutics, Inc. (1)
Celsion CORP (3)
Century Therapeutics, Inc. (2)
Checkmate Pharmaceuticals, Inc. (1)
Coherus BioSciences, Inc. (1)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (1)
CONTRAFECT Corp (3)
Corbus Pharmaceuticals Holdings, Inc. (3)
Cortexyme, Inc. (5)
CTI BIOPHARMA CORP (3)
Cullinan Oncology, LLC (1)
CURIS INC (1)
Cyclacel Pharmaceuticals, Inc. (2)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (4)
CytomX Therapeutics, Inc. (8)
CYTORI THERAPEUTICS, INC. (1)
CYTRX CORP (1)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
DiaMedica Therapeutics Inc. (2)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (8)
Eagle Pharmaceuticals, Inc. (2)
Edge Therapeutics, Inc. (1)
Editas Medicine, Inc. (3)
Eiger BioPharmaceuticals, Inc. (12)
Elevation Oncology, Inc. (1)
Emerald Bioscience, Inc. (3)
Emergent BioSolutions Inc. (1)
Entera Bio Ltd. (2)
ENZON PHARMACEUTICALS, INC. (2)
Equillium, Inc. (1)
EXACT SCIENCES CORP (1)
Exelixis (1)
EXICURE, INC. (8)
FENNEC PHARMACEUTICALS INC. (2)
Fibrocell Science, Inc. (6)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (2)
Flexion Therapeutics Inc (1)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (2)
Frequency Therapeutics, Inc. (4)
FS Development Corp. (2)
FS Development Corp. II (2)
G1 Therapeutics, Inc. (1)
Gain Therapeutics, Inc. (1)
GALECTIN THERAPEUTICS INC (2)
Galecto Inc. (1)
Gemphire Therapeutics Inc. (5)
GENOCEA BIOSCIENCES, INC. (1)
Genprex, Inc. (1)
GERON CORP (2)
Gilead Sciences (1)
Grail, Inc. (1)
Gritstone Oncology, Inc. (1)
GTX INC (2)
HALOZYME THERAPEUTICS INC (1)
Health Sciences Acquisitions Corp (2)
HEAT BIOLOGICS, INC. (1)
HERON THERAPEUTICS, INC. (1)
HISTOGENICS CORP (4)
iBio, Inc. (2)
IDEAYA Biosciences, Inc. (1)
IDERA PHARMACEUTICALS, INC. (6)
Imago BioSciences, Inc. (2)
IMMUNE PHARMACEUTICALS INC (2)
Immune Therapeutics, Inc. (1)
IMMUNOGEN INC (1)
Immunome Inc. (1)
IMMUNOMEDICS INC (2)
Incyte (1)
Inhibrx, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (2)
Inozyme Pharma, Inc. (2)
INSMED Inc (2)
Inspyr Therapeutics, Inc. (1)
Instil Bio, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
Invitae Corp (1)
IONIS PHARMACEUTICALS INC (1)
IRONWOOD PHARMACEUTICALS INC (2)
Isoray, Inc. (5)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (4)
Karyopharm Therapeutics Inc. (1)
KBL MERGER CORP. IV (2)
Keros Therapeutics, Inc. (1)
Kezar Life Sciences, Inc. (1)
Kiniksa Pharmaceuticals, Ltd. (1)
Kiromic Biopharma, Inc. (2)
Kura Oncology, Inc. (3)
LA JOLLA PHARMACEUTICAL CO (3)
LianBio (2)
Ligand Pharmaceuticals Incorporated (4)
Lyell Immunopharma, Inc. (2)
MARIZYME INC (1)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (9)
Matinas BioPharma Holdings, Inc. (4)
MAXCYTE, INC. (1)
MEDICINOVA INC (3)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (2)
MERRIMACK PHARMACEUTICALS INC (10)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (5)
MiMedx Group, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (4)
Mirati Therapeutics, Inc. (4)
Moderna, Inc. (2)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (3)
Monte Rosa Therapeutics, Inc. (1)
Myovant Sciences Ltd. (2)
Myriad Genetics, Inc. (3)
NANOVIRICIDES, INC. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (3)
NEUROTROPE BIOSCIENCE, INC. (3)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (5)
NexImmune, Inc. (1)
Nkarta, Inc. (1)
NTN BUZZTIME INC (8)
Ohr Pharmaceutical Inc (2)
Olema Pharmaceuticals, Inc. (2)
OncBioMune Pharmaceuticals, Inc (1)
OncoCyte Corp (4)
ONCOSEC MEDICAL Inc (4)
OPGEN INC (1)
Ophthotech Corp. (2)
Opko Health, Inc. (2)
Orchard Therapeutics plc (1)
Organicell Regenerative Medicine, Inc. (1)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (4)
Outlook Therapeutics, Inc. (3)
Passage BIO, Inc. (3)
PDL BIOPHARMA, INC. (5)
Pfenex Inc. (3)
Phio Pharmaceuticals Corp. (1)
PIERIS PHARMACEUTICALS, INC. (1)
POLARITYTE, INC. (3)
Praxis Precision Medicines, Inc. (1)
PRECISION BIOSCIENCES INC (1)
Prelude Therapeutics Inc (1)
PROGENITY, INC. (1)
Protagonist Therapeutics, Inc (1)
PROTEON THERAPEUTICS INC (5)
PROTEOSTASIS THERAPEUTICS, INC. (6)
Prothena Corp plc (1)
PTC THERAPEUTICS, INC. (1)
Radius Health, Inc. (5)
REGENXBIO Inc. (1)
RenovaCare, Inc. (1)
Repare Therapeutics Inc. (1)
Replimune Group, Inc. (4)
Retrophin, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (3)
RHYTHM PHARMACEUTICALS, INC. (2)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (7)
Savara Inc (6)
Scholar Rock Holding Corp (2)
SELECTA BIOSCIENCES INC (2)
SELLAS Life Sciences Group, Inc. (1)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (2)
Sesen Bio, Inc. (2)
Sierra Oncology, Inc. (2)
Solid Biosciences Inc. (3)
SOLIGENIX, INC. (2)
Spectrum Pharmaceuticals, Inc. (1)
Spero Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (4)
SQZ Biotechnologies Co (3)
SUNESIS PHARMACEUTICALS INC (1)
Surface Oncology, Inc. (1)
SYNLOGIC, INC. (5)
Synthetic Biologics, Inc. (3)
T2 Biosystems, Inc. (2)
TENAX THERAPEUTICS, INC. (4)
TG THERAPEUTICS, INC. (1)
Translate Bio, Inc. (1)
Trovagene, Inc. (1)
TScan Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
uniQure N.V. (3)
Unity Biotechnology, Inc. (1)
Unum Therapeutics Inc. (1)
UroGen Pharma Ltd. (4)
VACCINEX, INC. (1)
Vaxart, Inc. (1)
Vaxcyte, Inc. (1)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (3)
Verastem, Inc. (1)
Vertex Pharmaceuticals Inc (1)
VICAL INC (2)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (1)
Voyager Therapeutics, Inc. (4)
vTv Therapeutics Inc. (1)
WINDTREE THERAPEUTICS INC (4)
Xencor Inc (2)
Xilio Therapeutics, Inc. (1)
XOMA Corp (1)
Y-mAbs Therapeutics, Inc. (1)
YIELD10 BIOSCIENCE, INC. (1)
ZIOPHARM ONCOLOGY INC (4)
Zymeworks Inc. (2)

Recent Contracts

Separation Agreement and General Release, effective as of September 27, 2023, between Organovo Holdings, Inc. and Jeffrey Miner (ORGANOVO HOLDINGS, INC., Filed With SEC on September 22, 2023)
Second Amendment to Separation Agreement and General Release dated September 18, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on September 21, 2023)
Separation Agreement between Black Diamond Therapeutics, Inc. and Dr. Epstein, dated as of September 17, 2023 (Black Diamond Therapeutics, Inc., Filed With SEC on September 18, 2023)
Separation Agreement and General Release, effective as of September 15, 2023, between Organovo Holdings, Inc. and Tom Jurgensen (ORGANOVO HOLDINGS, INC., Filed With SEC on September 12, 2023)
Separation Agreement and Release dated as of September 3, 2023 by and between Kirsten Gruis, M.D. and DiaMedica USA, Inc (DiaMedica Therapeutics Inc., Filed With SEC on September 5, 2023)
Separation Agreement with David Spellman, dated June 9, 2023 and Amendment to Separation Agreement dated July 6, 2023 (Akebia Therapeutics, Inc., Filed With SEC on August 28, 2023)
Amendment to Separation Agreement and General Release dated August 15, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on August 21, 2023)
Executive Separation Agreement, dated as of August 15, 2023, entered into by and between Aceragen, Inc. and John Taylor (IDERA PHARMACEUTICALS, INC., Filed With SEC on August 16, 2023)
Separation Agreement, by and between the Registrant and Sumita Ray, dated as of April 14, 2023 (Instil Bio, Inc., Filed With SEC on August 14, 2023)
Transition Services and Separation Agreement, dated August 9, 2023, between AgeX Therapeutics, Inc. and Michael D. West (AgeX Therapeutics, Inc., Filed With SEC on August 14, 2023)
Executive Transition and Separation Agreement, dated as of May 22, 2023, between Solid Biosciences Inc. and Carl Morris (Solid Biosciences Inc., Filed With SEC on August 14, 2023)
Separation Agreement and General Release, dated June 20, 2023, by and between Qualigen Therapeutics, Inc. and Amy Broidrick (RITTER PHARMACEUTICALS INC, Filed With SEC on August 14, 2023)
First Amendment to the Separation and Release Agreement of Matthias Schroff, dated June 12, 2023, among Exicure, Inc. and Matthias Schroff (EXICURE, INC., Filed With SEC on August 11, 2023)
Separation and Release Agreement by and between Ocuphire Pharma, Inc. and Mina Sooch, dated June 8, 2023 (REXAHN PHARMACEUTICALS, INC., Filed With SEC on August 11, 2023)
Separation and Release Agreement, dated May 27, 2023, among Exicure, Inc. and Sarah Longoria (EXICURE, INC., Filed With SEC on August 11, 2023)
Separation and Release Agreement, dated April 26, 2023, among Exicure, Inc. and Elias Papadimas (EXICURE, INC., Filed With SEC on August 11, 2023)
Separation and Release Agreement, dated April 26, 2023, among Exicure, Inc. and Matthias Schroff (EXICURE, INC., Filed With SEC on August 11, 2023)
Transition and Separation Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D (Spero Therapeutics, Inc., Filed With SEC on August 10, 2023)
Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of May 24, 2023 (Adverum Biotechnologies, Inc., Filed With SEC on August 10, 2023)
Separation Agreement between the Registrant and Ajim Tamboli, effective as of August 8, 2023 (Monte Rosa Therapeutics, Inc., Filed With SEC on August 10, 2023)
Release and Separation Agreement (Lyell Immunopharma, Inc., Filed With SEC on August 8, 2023)
Separation Agreement and Release, dated as of May 18, 2023 by and between Jean Franchi and Replimune, Inc (Replimune Group, Inc., Filed With SEC on August 3, 2023)
Separation Agreement, dated May 16, 2023, between the Registrant and Michelle Robertson (Editas Medicine, Inc., Filed With SEC on August 2, 2023)
Separation Agreement, dated as of July 28, 2023, by and between Frequency Therapeutics, Inc. and Christopher Loose (Frequency Therapeutics, Inc., Filed With SEC on July 31, 2023)
Separation Agreement, effective June 26, 2023, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault (Cyclerion Therapeutics, Inc., Filed With SEC on July 28, 2023)
Separation and Release Agreement between the Company and Brian Drazba, dated June 16, 2023 (MEI Pharma, Inc., Filed With SEC on July 27, 2023)
Separation Agreement and General Release by and between Matthew Shatzkes and Aditxt, Inc (ADiTx Therapeutics, Inc., Filed With SEC on July 27, 2023)
Separation and Release Agreement, dated July 14, 2023 (AmpliPhi Biosciences Corp, Filed With SEC on July 19, 2023)
Separation Agreement, by and between Surrozen Inc. and Dr. Wen-Chen Yeh, dated July 18, 2023 (Consonance-HFW Acquisition Corp., Filed With SEC on July 19, 2023)
Separation Agreement by and between the Company and Todd Wood (Constellation Alpha Capital Corp., Filed With SEC on July 13, 2023)
First Amendment to the Separation and Release Agreement of Matthias Schroff, dated June (EXICURE, INC., Filed With SEC on June 14, 2023)
Separation Agreement and General Release, dated May 15, 2023, by and between Diffusion Pharmaceuticals Inc. and William K. Hornung (Diffusion Pharmaceuticals Inc., Filed With SEC on May 19, 2023)
Separation Agreement and General Release of Claims, dated May 15, 2023, by and between Pardes Biosciences, Inc. and Brian P. Kearney, PharmD (FS Development Corp. II, Filed With SEC on May 18, 2023)
Separation Agreement, dated January 5, 2023, between the Company and Shawn M. Leland (Elevation Oncology, Inc., Filed With SEC on May 15, 2023)
Separation Agreement between Marker Therapeutics, Inc. and Peter Hoang dated as of April 27, 2023 (Marker Therapeutics, Inc., Filed With SEC on May 15, 2023)
Separation Agreement by and between Frequency Therapeutics, Inc. and Wendy Arnold, dated February 17, 2023 (Frequency Therapeutics, Inc., Filed With SEC on May 12, 2023)
Separation Agreement, dated March 8, 2023, by and between Bittoo (Applied Molecular Transport Inc., Filed With SEC on May 11, 2023)
Separation Agreement and Release by and between the Company and Hyam Levitsky, M.D., dated January 23, 2023 (Century Therapeutics, Inc., Filed With SEC on May 11, 2023)
Separation Agreement, dated April 28, 2023, by and between Tahir Mahmood and Applied Molecular Transport Inc (Applied Molecular Transport Inc., Filed With SEC on May 11, 2023)
Separation Agreement dated as of May 8, 2023 between Theriva Biologics, Inc. and Frank Tufaro (Synthetic Biologics, Inc., Filed With SEC on May 11, 2023)